Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

DirkJan Hijnen

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
European Journal of Immunology|November 5, 2016
Atopic dermatitis: A tale of two distinct pathomechanisms that make you itchEdward F Knol, DirkJan Hijnen
Immunology and Allergy Clinics of North America|November 26, 2016
Current and Future Biomarkers in Atopic DermatitisJudith L Thijs, Marjolein S de Bruin-Weller, DirkJan Hijnen
Acta Dermato-Venereologica|March 10, 2025
Long-term Outcomes of New Systemic Agents in Atopic Dermatitis: Drug Survival Analyses and Treatment Patterns in Daily PracticeAnne R Schlosser, Lars Nijman, Renske Schappin, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 21, 2023
Upadacitinib treatment in a real-world difficult-to-treat atopic dermatitis patient cohortAnne R Schlösser, Neill Boeijink, Jill Olydam, et al.
Acta Dermato-Venereologica|April 28, 2025
Systemic Treatments for Lichen Planopilaris and Frontal Fibrosing Alopecia: A Retrospective Study of 315 PatientsMathias Willaert, Tristan Van Dongen, Petra Dikrama, et al.
Journal of the American Academy of Dermatology|September 10, 2014
Utility of serum thymus and activation-regulated chemokine as a biomarker for monitoring of atopic dermatitis severityJanneke Landheer, Marjolein de Bruin-Weller, Chantal Boonacker, et al.
Journal of Clinical Medicine|August 5, 2015
New Developments in Biomarkers for Atopic DermatitisJudith L Thijs, Wouter van Seggelen, Carla Bruijnzeel-Koomen, et al.
Acta Dermato-Venereologica|April 7, 2025
Real-world Effectiveness and Safety of Janus Kinase Inhibitors in Alopecia Areata: A Retrospective Cohort Study of 72 PatientsSophie C Van Helmond, Mathias Willaert, Viet-Hoa Nguyen, et al.
Plos One|April 20, 2026
Serum proteomic changes in atopic dermatitis patients treated with cyclosporineJill Isabelle Olydam, Thomas Litman, Tamar Nijsten, et al.
The Journal of Allergy and Clinical Immunology|January 31, 2021
Biomarkers in atopic dermatitis-a review on behalf of the International Eczema CouncilYael Renert-Yuval, Jacob P Thyssen, Robert Bissonnette, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
European Journal of Immunology|November 5, 2016
Atopic dermatitis: A tale of two distinct pathomechanisms that make you itchEdward F Knol, DirkJan Hijnen
Immunology and Allergy Clinics of North America|November 26, 2016
Current and Future Biomarkers in Atopic DermatitisJudith L Thijs, Marjolein S de Bruin-Weller, DirkJan Hijnen
Acta Dermato-Venereologica|March 10, 2025
Long-term Outcomes of New Systemic Agents in Atopic Dermatitis: Drug Survival Analyses and Treatment Patterns in Daily PracticeAnne R Schlosser, Lars Nijman, Renske Schappin, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 21, 2023
Upadacitinib treatment in a real-world difficult-to-treat atopic dermatitis patient cohortAnne R Schlösser, Neill Boeijink, Jill Olydam, et al.
Acta Dermato-Venereologica|April 28, 2025
Systemic Treatments for Lichen Planopilaris and Frontal Fibrosing Alopecia: A Retrospective Study of 315 PatientsMathias Willaert, Tristan Van Dongen, Petra Dikrama, et al.
Journal of the American Academy of Dermatology|September 10, 2014
Utility of serum thymus and activation-regulated chemokine as a biomarker for monitoring of atopic dermatitis severityJanneke Landheer, Marjolein de Bruin-Weller, Chantal Boonacker, et al.
Journal of Clinical Medicine|August 5, 2015
New Developments in Biomarkers for Atopic DermatitisJudith L Thijs, Wouter van Seggelen, Carla Bruijnzeel-Koomen, et al.
Acta Dermato-Venereologica|April 7, 2025
Real-world Effectiveness and Safety of Janus Kinase Inhibitors in Alopecia Areata: A Retrospective Cohort Study of 72 PatientsSophie C Van Helmond, Mathias Willaert, Viet-Hoa Nguyen, et al.
Plos One|April 20, 2026
Serum proteomic changes in atopic dermatitis patients treated with cyclosporineJill Isabelle Olydam, Thomas Litman, Tamar Nijsten, et al.
The Journal of Allergy and Clinical Immunology|January 31, 2021
Biomarkers in atopic dermatitis-a review on behalf of the International Eczema CouncilYael Renert-Yuval, Jacob P Thyssen, Robert Bissonnette, et al.
Pageof 4